Dallas, TX 的 子宮頸癌 臨床試驗
13 項針對 子宮頸癌 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
招募中4 期
- Parkland Health & Hospital System, Dallas
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- 還有 2 項
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
招募中1/2 期
- Baylor, Scott and White Research Institute, Dallas
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Texas Oncology, P.A., Dallas
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
招募中
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-WIlliam P. Clements Jr. University Hospital, Dallas
- 還有 2 項
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
招募中2 期
- UT Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
招募中1 期
- Mary Crowley Cancer Research, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
招募中1/2 期
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
其他城市的 子宮頸癌 試驗
- Houston, TX34 項研究
- New York City, NY19 項研究
- Nashville, TN19 項研究
- Boston, MA18 項研究
- Los Angeles, CA16 項研究
- Arlington, VA16 項研究
- San Antonio, TX14 項研究
- St. Louis, MO13 項研究
- Orlando, FL12 項研究
- Chicago, IL12 項研究
- Atlanta, GA11 項研究
- Columbus, OH11 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。